Lill-Tove Busund Selected Research

Vascular Endothelial Growth Factor Receptor-3 (Flt 4)

1/2015	Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.
7/2011	Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.
3/2011	Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor size.
12/2010	Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
5/2009	Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
4/2009	Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy.
2/2009	VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells.
11/2007	Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lill-Tove Busund Research Topics

Disease

53	Neoplasms (Cancer) 01/2019 - 08/2005
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 08/2008
12	Sarcoma (Soft Tissue Sarcoma) 01/2014 - 01/2010
11	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 06/2010
6	Carcinogenesis 01/2019 - 01/2011
6	Neoplasm Metastasis (Metastasis) 01/2016 - 02/2009
5	Lung Neoplasms (Lung Cancer) 01/2016 - 11/2007
5	Hypoxia (Hypoxemia) 02/2014 - 05/2011
4	Breast Neoplasms (Breast Cancer) 01/2016 - 04/2011
3	Carcinoma (Carcinomatosis) 01/2016 - 06/2010
3	Margins of Excision 01/2011 - 01/2010
2	Adenocarcinoma 01/2017 - 11/2012
2	Lymphatic Metastasis 01/2015 - 02/2009
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2012 - 03/2011
1	Disease Progression 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 06/2015
1	Wounds and Injuries (Trauma) 11/2007

Drug/Important Bio-Agent (IBA)

12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 11/2007
11	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2011
11	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2009
8	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2015 - 11/2007
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 09/2008
6	Indicators and Reagents (Reagents)IBA 02/2012 - 11/2007
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 04/2011
5	Estrogen ReceptorsIBA 01/2018 - 04/2011
5	LigandsIBA 04/2017 - 12/2010
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2015 - 11/2007
4	Hormones (Hormone)IBA 01/2018 - 11/2011
4	Vascular Endothelial Growth FactorsIBA 11/2015 - 02/2009
4	Macrophage Colony-Stimulating FactorIBA 02/2015 - 10/2009
4	Vascular Endothelial Growth Factor CIBA 01/2015 - 11/2007
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2012 - 05/2009
3	Protein Isoforms (Isoforms)IBA 01/2018 - 10/2009
3	AndrogensIBA 01/2018 - 01/2015
3	SteroidsIBA 01/2018 - 11/2011
3	Aromatase (CYP19)IBA 01/2018 - 01/2016
3	Transforming Growth Factor beta (TGF-beta)IBA 05/2012 - 06/2010
3	Carbonic Anhydrase IXIBA 01/2012 - 05/2011
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2012 - 05/2011
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Programmed Cell Death 1 ReceptorIBA 04/2017 - 01/2017
2	Keratins (Keratin)IBA 01/2016 - 08/2005
2	Platelet-Derived Growth FactorIBA 01/2014 - 04/2009
2	Capsules (Microcapsules)IBA 05/2012 - 02/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2012 - 06/2010
2	Interleukin-10 (Interleukin 10)IBA 02/2012 - 06/2010
2	Lactate Dehydrogenase 5IBA 06/2011 - 05/2011
2	CytokinesIBA 04/2011 - 01/2011
2	VimentinIBA 03/2011 - 08/2005
2	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2011 - 01/2011
2	ParaffinIBA 06/2010 - 10/2009
1	progesterone receptor BIBA 01/2018
1	AntibodiesIBA 04/2017
1	B7-H1 AntigenIBA 04/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	CK-34 beta E12IBA 01/2016
1	EnzymesIBA 01/2016
1	Keratin-7 (Cytokeratin 7)IBA 01/2016
1	Chemokine CXCL16IBA 10/2015
1	CXC ChemokinesIBA 10/2015
1	Progesterone FDA LinkGeneric 06/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2014
1	Angiogenic ProteinsIBA 02/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2014
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2014
1	Conditioned Culture MediaIBA 02/2013
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 02/2012
1	Matrix Metalloproteinases (MMPs)IBA 02/2012
1	VaccinesIBA 04/2011
1	ChemokinesIBA 04/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2011
1	protein kinase C zetaIBA 03/2011
1	Cadherins (E-Cadherin)IBA 03/2011
1	NF-kappa B (NF-kB)IBA 03/2011
1	fascinIBA 03/2011
1	AngiopoietinsIBA 01/2011
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2011
1	delta proteinIBA 12/2010
1	Epidermal Growth Factor (EGF)IBA 10/2010
1	SilverIBA 10/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2010
1	Formaldehyde (Formol)FDA Link 06/2010
1	platelet-derived growth factor C (PDGF-C)IBA 09/2008
1	platelet-derived growth factor AIBA 09/2008
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2007
1	Vascular Endothelial Growth Factor DIBA 11/2007
1	Insulin (Novolin)FDA Link 11/2007

Therapy/Procedure

6	Therapeutics 01/2018 - 08/2008
5	Prostatectomy (Retropubic Prostatectomy) 11/2017 - 06/2014
4	Radiotherapy 05/2013 - 01/2012
2	Adjuvant Radiotherapy 05/2013 - 04/2009
1	Drug Therapy (Chemotherapy) 01/2012
1	Immunotherapy 04/2011